Opus Genetics
Price & Volume
Stats
See moreOpen | $4.05 |
Previous Close | $4.08 |
Day Range | $4.05-$4.29 |
52W Range | $0.90-$5.81 |
Market Cap | $336M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $11.9M |
Revenue Growth (YoY) | -50.6% |
Gross Profit (12 Mos) | -$21.4M |
Diluted EPS | -$1.31 |
News
See moreYahoo Finance • 7 days ago
Opus Genetics Highlights Five Gene Therapy Programs Targeting Significant Unmet Need in Patients with Inherited Retinal Diseases
Yahoo Finance • 2 months ago
Opus Genetics Presents Clinical and Preclinical Data at ARVO 2026 Demonstrating Continued Pipeline Advancement in Inherited Retinal Diseases
Yahoo Finance • 2 months ago
Here is Why Opus Genetics (IRD) is One of the Best Performing NASDAQ Stocks
Yahoo Finance • 2 months ago
Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program
About
CEO | Dr. George Magrath M.B.A., M.D., M.S. |
Address | 8 Davis Drive, Durham, NC, United States, 27713 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 27 |